Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03614598
Other study ID # Local/2008/JL- 02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 22, 2009
Est. completion date September 5, 2012

Study information

Verified date July 2018
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ≤ 5%


Recruitment information / eligibility

Status Completed
Enrollment 546
Est. completion date September 5, 2012
Est. primary completion date September 5, 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must have given their free and informed consent and signed the consent form

- The patient must be a member or beneficiary of a health insurance plan

- Adult patients > 18

- ASA score I-III

- Patient scheduled to undergo elective surgery lasting less than two hours under general anaesthetic without tracheal intubation

- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study

- The subject refuses to sign the consent

- It is impossible to give the subject informed information

- The patient is under safeguard of justice or state guardianship

- The patient is pregnant or breastfeeding

- Emergency surgery

- Sore thoat = 1 month

- Risk of aspiration of gastric contents

- Body mass index (BMI) > 35

- Patients with expected airway difficulties

- Contra-indication for any of the devices (symptomatic hiatal hernias, pathological obesity, poly trauma or serious injury, delayed gastric emptying, use of opiates during fasting)

- Patients who are not fasting for routine and emergency anesthesia

- Trismus, limited mouth opening, abscess or pharyngoperilaryngeal mass

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Insertion of LMA-UNIQUE(TM) device
LMA-UNIQUE(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation
Insertion of LMA-SUPREME(TM) device
LMA-SUPREME(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation
Insertion of I-GEL(R) device
I-GEL(R) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation

Locations

Country Name City State
France CHU Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of pharyngolaryngeal postoperative pain of the three devices Sore throat Y/N 24 hours
Secondary Pharyngolaryngeal postoperative pain between groups Sore throat Y/N 2 hours
Secondary Time taken to place device From first attempt at introduction until acceptable exhaled CO2 curve attained (seconds) End of surgery (maximum 2 hours)
Secondary Number of attempts needed to place device End of surgery (maximum 2 hours)
Secondary Necessity of altering the size of the device Y/N End of surgery (maximum 2 hours)
Secondary Any patient movement during procedure Y/N End of surgery (maximum 2 hours)
Secondary Difficulty of insertion 5-point scale: very easy-failure End of surgery (maximum 2 hours)
Secondary Total leakage pressure of the devices measured directly by the respirator End of surgery (maximum 2 hours)
Secondary Ventilatory pressure of the devices End of surgery (maximum 2 hours)
Secondary Device stability during surgery Need to change the management system airways (orotracheal intubation or others) Y/N End of surgery (maximum 2 hours)
Secondary Difficulty of device removal 4-point scale: very easy-very difficult End of surgery (maximum 2 hours)